{
    "clinical_study": {
        "@rank": "72320", 
        "acronym": "ABSORB-ACS", 
        "arm_group": {
            "arm_group_label": "acute coronary syndrome", 
            "description": "patients with acute myocardial infarction who are undergoing coronary angioplasty.  MACE at 30 days and 1 year will be assessed . The acute recoil after implantation of bioabsorbable stents will also be assessed"
        }, 
        "brief_summary": {
            "textblock": "The aim of our study is to evaluate the clinical outcomes at 30 days and 1 year (cardiac\n      death, myocardial infarction, target lesion revascularization (TLR), target vessel\n      revascularization (TVR), thrombosis of the device in patients who are undergoing angioplasty\n      in myocardial infarction and in which bioabsorbable stent was implanted (BVS). Additionally,\n      we will evaluate the acute recoil after implantation of bioabsorbable stents. A 24 months\n      follow-up , by means of coronary angiography accompanied by QCA and assessment with\n      intracoronary ultrasound (IVUS) and VH (virtual histology) is scheduled."
        }, 
        "brief_title": "Study of ABSORB Stent in Acute Myocardial Infarction", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Myocardial Infarction", 
            "Artery; Deformity, Coronary (Acquired)"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Infarction", 
                "Myocardial Infarction", 
                "Arteriovenous Fistula", 
                "Acute Coronary Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "The drug -eluting stents (drug eluting stents , DES) are currently used routinely in the\n      course of coronary angioplasty ( percutaneous coronary intervention , PCI ) and have\n      significantly reduced the incidence of adverse events during follow-up in the medium and\n      long term .\n\n      However, the persistence of the metal structure of these devices within the coronary artery\n      over time  adds no additional benefit but , on the contrary , it is potentially harmful\n      because it may predispose to coronary thrombosis even after years of implantation, can alter\n      the structure of the vessel for remodeling phenomena, can decrease a coronary vasomotion and\n      reducing the possibilily of a future surgery. The recent development of new devices such as\n      bioabsorbable vascular scaffold \" BVS \" release of antiproliferative drug ( everolimus ),\n      could provide new clinical advantages especially in patients who are revascularized during\n      acute myocardial infarction. These patients are at higher risk of MACE and stent thrombosis\n      late .\n\n      The aim of our study is to evaluate the clinical outcomes conventional to 30 days and 1\n      year, such as cardiac death, myocardial infarction, target lesion revascularization(TLR ),\n      target vessel revascularization (TVR ), thrombosis of the device in patients who undergo\n      angioplasty in the course of acute coronary syndrome and in which it was implanted\n      bioabsorbable stent ( BVS ). The acute recoil after implantation of bioresorbable vascular\n      scaffold  will also be assessed Finally,  a follow-up of 24 months we will conduct, by means\n      of coronary angiography accompanied by QCA and IVUS with VH ."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients older than 18 years with acute coronary syndrome (STEMI and NSTEMI)  will be\n             enrolled\n\n        Exclusion Criteria:\n\n          -  patients with these characteristics will be excluded: cardiogenic shock (defined as\n             systolic blood pressure less than 80 mmHg for more than 30 minutes or the need for\n             compressors or intravenous-intraaortic balloon counterpulsation), history of bleeding\n             diathesis, history of leukopenia , thrombocytopenia, or severe hepatic or renal\n             dysfunction,  a non-cardiac disease associated with a life expectancy of less than\n             one year,  participating in another study, or  not able to give informed consent due\n             to a prolonged resuscitation cardiopulmonary."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with acute coronary syndrome who are undergoing coronary angioplasty."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 2, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02071342", 
            "org_study_id": "350/O/13"
        }, 
        "intervention": {
            "arm_group_label": "acute coronary syndrome", 
            "description": "patients with acute coronary syndrome and coronary angioplasty with bioresorbable vascular scaffold.", 
            "intervention_name": "angioplasty", 
            "intervention_type": "Procedure", 
            "other_name": [
                "bioabsorbable everolimus-eluting coronary stent", 
                "everolimus-eluting bioresorbable vascular scaffold (BVS)"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Everolimus"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "acute myocardial infarction", 
            "bioresorbable vascular scaffold", 
            "percutaneous coronary intervention"
        ], 
        "lastchanged_date": "February 23, 2014", 
        "location": {
            "contact": {
                "email": "menichelli747@yahoo.com", 
                "last_name": "Maurizio Menichelli, MD", 
                "phone": "+39 3382642317"
            }, 
            "facility": {
                "address": {
                    "city": "Frosinone", 
                    "country": "Italy", 
                    "zip": "030100"
                }, 
                "name": "Division of interventional cardiology, Umberto I Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Giancarlo Di Ruzza, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Pasquale Mollo, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Duino Boncompagni, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Marco Cesario, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Andrea Mazza, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of ABSORB Stent in Acute Coronary Syndrome", 
        "other_outcome": {
            "description": "Evaluation of the conformability of the stent and the vessel curvature and angle before and after implantation of the device", 
            "measure": "conformability", 
            "safety_issue": "Yes", 
            "time_frame": "immediately after implantation of the device"
        }, 
        "overall_contact": {
            "email": "menichelli747@yahoo.com", 
            "last_name": "Maurizio Menichelli, MD", 
            "phone": "+393382642317"
        }, 
        "overall_official": {
            "affiliation": "Division of Cardiology \"Fabrizio Spaziani\" Hospital Frosinone, Italy", 
            "last_name": "Maurizio Menichelli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "MACE at 30 days and 1 year (Death, MI, TLR and TVR) and thrombosis of the device in patients with acute coronary syndrome undergoing PCI with stenting bioresorbable", 
            "measure": "MACE  (Death, MI, TLR and TVR)", 
            "safety_issue": "Yes", 
            "time_frame": "One year after index procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02071342"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Umberto I Hospital, Frosinone Italy", 
            "investigator_full_name": "Menichelli Maurizio", 
            "investigator_title": "Director Division of Cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Evaluation of acute recoil after implantation of bioabsorbable stent (BVS).", 
            "measure": "Acute stent Recoil", 
            "safety_issue": "Yes", 
            "time_frame": "Within ten minutes after scaffold implantation"
        }, 
        "source": "Umberto I Hospital, Frosinone Italy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Umberto I Hospital, Frosinone Italy", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}